Tianjin Bokelin

Tianjin Bokelin is a Chinese biotechnology company specializing in chromatography separation technology and the production of high-performance chromatography media. Founded in 2002, the company provides essential tools and services for the purification of biological drugs, including monoclonal antibodies, recombinant proteins, and vaccines. Their product portfolio includes a variety of resins such as ion exchange, affinity, and hydrophobic interaction media, alongside industrial-scale chromatography columns. In addition to manufacturing, Tianjin Bokelin offers contract research and manufacturing services focused on downstream process development and optimization. The company plays a significant role in the domestic Chinese bioprocessing market, supporting both research-scale and industrial-scale production. Their expertise in resin synthesis and application helps biopharmaceutical companies reduce costs and improve the efficiency of their purification workflows.